Company intelligence / Profile preview

Hangzhou Accurate Bio-Medicine

Hangzhou, Zhejiang, China

Ownership: Private
Development stage: Other

Overview

Hangzhou Accurate Bio-Medicine is a biotechnology company specializing in precision medicine and molecular diagnostics, particularly in the field of oncology. Founded in 2014 and headquartered in Hangzhou, China, the company develops and manufactures in vitro diagnostic (IVD) kits using advanced technologies such as ARMS-PCR and Next-Generation Sequencing (NGS). Their product portfolio focuses on companion diagnostics for major cancers, including lung, colorectal, and breast cancer, targeting biomarkers like EGFR, KRAS, and ALK. Accurate Bio-Medicine operates a GMP-certified facility and aims to provide clinicians with accurate tools for personalized cancer treatment.

Therapeutic areas: Oncology
Modalities: DiagnosticIn vitro diagnostic
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Hangzhou Accurate Bio-Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hangzhou Accurate Bio-Medicine.

Explore the full profile